Global Tuberculin Market Drivers and Regional Status: Showing a CAGR of 6.27% During the Forecast Period

Global Tuberculin Market Overview

According to Global Market Monitor, the global tuberculin market will reach $658.31 million in 2024 with a CAGR of 6.27% from 2024 to 2029.

Tuberculin is a combination of proteins that are used in the diagnosis of tuberculosis. This use is referred to as the tuberculin skin test and is recommended only for those at high risk. The injection is done into the skin. After 48 to 72 hours if there is more than a five to ten millimeter area of swelling the test is considered positive.

High Incidence Drives the Growth of Demand.

Tuberculosis is a chronic and slow-onset infectious disease caused by tuberculosis bacillus infection. The incubation period was 4 to 8 weeks and 80% of them occur in the lungs, and other parts (neck lymph, meninges, peritoneum, intestine, skin, bone) can also be secondary to infection. Respiratory transmission between people is the main mode of transmission of the disease. The source of infection is tuberculosis patients who are exposed to bacteria. With the spread of environmental pollution and AIDS, the incidence of tuberculosis has become more and more intense. Except for a few cases of acute onset, the clinical manifestations are mostly chronic. It often has systemic symptoms such as low fever and fatigue and respiratory manifestations such as cough and hemoptysis.

Tuberculosis is still an important cause of disease and death in developing countries. Tuberculosis is the leading killer of adult infections worldwide, second only to HIV. In addition to its health impact, the disease has had a huge impact on the economy, making tuberculosis the main cause of poverty. Over the past few decades, the number of patients with TB has soared. This factor has led to an increased demand for research on effective diagnostic techniques to improve patient outcomes and increase the accuracy of diagnosis of these diseases.

Policies Can Help Reduce the Burden of TB

Governments have strengthened TB diagnostic policies to reduce the global burden. The demand for diagnostics is expected to grow in the coming years as the level of awareness of the severity of the disease in countries increases dramatically. Many countries are emphasizing policies to improve TB diagnosis. Increasing awareness of the primary focus of high TB burden countries on reducing TB cases is expected to strongly drive sales of TB diagnostic tools in the coming years. The public should master the core knowledge of tuberculosis prevention and control and raise awareness of prevention and control. In September 2022, for example, the President of India launched Pradhan Mantri TB Mukt Bharat Abhiyaan with a vision to eliminate TB by 2025.

Asia Pacific will witness the fastest growth during the forecast period, and the growth of the market in this region is due to the increasing prevalence of infectious diseases in the population. TB is considered one of the leading causes of death in the region, with the highest number of cases in Indonesia, India, the Philippines, China, Pakistan, Bangladesh (3.6%), South Africa and Nigeria. According to the World Health Organization, two-thirds of the world's TB cases have been observed in these eight countries.

By Type	PPD-S
	PPD-RT23
	Others
By Application	Human Use
	Animal Use

For more industry information, please refer to our latest released "2023 Global Tuberculin Market Analysis Report, Key Competitors, Market Effect Factors, Growth, And Forecast".